Hereditary deficiencies in the protein C pathway in central retinal artery occlusion and branch retinal artery occlusion;Hereditare storungen des protein-C-systems bei zentralarterien- und arteriolenastverschlussen

Klinische Monatsblatter fur Augenheilkunde

Volumn 215, Issue 1, 1999, Pages 33-36

  Greiner, Kathrin ^a   Hafner, Gerd ^a   Prellwitz, Winfried ^a   Pfeiffer, Norbert ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

APC resistance; Branch retinal artery occlusion; Central retinal artery occlusion; Thrombophilia

Indexed keywords

ACTIVATED PROTEIN C; PROTEIN C; PROTEIN S;

ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; BLOOD CLOTTING FACTOR 5 DEFICIENCY; CAROTID ARTERY OBSTRUCTION; CENTRAL RETINA ARTERY OCCLUSION; CLINICAL ARTICLE; DIABETES MELLITUS; GENETIC DISORDER; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RISK FACTOR; THROMBOPHILIA; ACTIVATED PROTEIN C RESISTANCE; BLOOD; DIFFERENTIAL DIAGNOSIS; FEMALE; GENETICS; MALE; METABOLISM; MIDDLE AGED; RETINA ARTERY OCCLUSION;

ACTIVATED PROTEIN C RESISTANCE; ADULT; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEIN C; PROTEIN C DEFICIENCY; PROTEIN S; PROTEIN S DEFICIENCY; RETINAL ARTERY OCCLUSION; RISK FACTORS; THROMBOPHILIA;

EID: 0032782823     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1034666     Document Type: Article

References (34)

1. Appleby RD, Olds RJ. The inherited basis of venous thrombosis. Pathology 1997; 29:341-347
2. Baranovskaya S, Kudinov S, Fomicheva E, Vasina V, Solovieva D, Khavinson V et al. Age as a risk factor for myocardial infarction in Leiden mutation carriers. Mol Genet Metab 1998; 64:155-157
3. Bertina RM, Koeleman BPC, KosterT, Rosendaal FR, Dirven RJ, De Ronde H et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369:64-67
4. Bertina RM, Rosendaal FR. Venous thrombosis - the interaction of genes and environment. N Engl J Med 1998; 338:1840-1841
5. Dahlbäck B. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis. J Internal Med 1997; 242:1-8
6. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C. Proc Natl AcadSci USA 1993; 90:1004-1008
7. Demarmels-Biasiutti F, Merlo C, Furlan M, Sulzer I, Binder BR, Lammle B. No association of APC resistance with myocardial infarction. Blood Coagul Fibrinolysis 1995; 6:456-459
8. Dulli DA, Luzzio CC, Williams EC, Schutta HS. Cerebral venous thrombosis and activated protein C resistance. Stroke 1996; 27:1731-1733
9. Gottlieb JL, Blice JP, Mestichelli B, Konkle BA, Benson WE. Activated protein C resistance, factor V Leiden, and central retinal vein occlusion in young adults. Arch Ophthalmol 1998; 116:577-579
10. Greven CM, Slusher MM, Weaver RG. Retinal arterial occlusions in young adults. Am J Ophthalmol 1995; 120:776-783
11. Hainaut P, Azerad MA, Lehmann F, Schlit AF, Zech F, Heusterspreute M et al. Prevalence of activated protein C resistance and analysis of clinical profile in thromboembolic patients. A Belgian prospective study. J Internal Med 1997; 241:427-433
12. Hillarp A, Zoller B, Svensson PJ, Dahlbäck B. The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thromb Haemost 1997; 78:990-992
13. Holm J, Zoller B, Svensson P, Berntorp E, Erhardt L, Dahlbäck B. Myocardial infarction associated with homozygous resistance to activated protein C. Lancet 1994; 344:952-953
14. Jorquera JI, Montoro JM, Fernandez MA, Aznar JA, Aznar J. Modified test for activated protein C resistance. Lancet 1994; 344:1162-1163
15. Kontula K, Ylikorkala A, Miettinen H, Vuorio A, Kauppinen-Makelin R, Hamalainen L et al. Arg506Gln Factor V Mutation (Factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction. Thromb Haemost 1995; 73:558-560
16. Lang GE, Spraul CW. Risikofaktoren retinaler Verschlußerkrankungen. Klin Monatsbl Augenheilkd 1997; 211:217-226
17. Larsson J, Olafsdottir E, Bauer B. Activated protein C resistance in young adults with central retinal vein occlusion. Br J Ophthalmol 1996; 80:200-202
18. Larsson J, Sellman A, Bauer B. Activated protein C resistance in patients with central retinal vein occlusion. Br J Ophthalmol 1997; 81:832-834
19. Lindblad B, Svensson P, Dahlbäck B. Arterial and venous thromboembolism with fatal outcome and resistance to activated protein C. Lancet 1994; 343:917
20. Makris M, Rosendaal FR, Preston FE. Familial thrombophilia: genetic risk factors and management. J Internal Med 1997; 242 Suppl 740:9-15
21. Olave T, Cornudella R, Homs C, Azaceta G, Tirado I, Gittierrez M. Incidence and clinical manifestations of activated protein C resistance and factor V Leiden in young patients with venous thromboembolic disease in Spain. Haematologica 1998, 83:378-380
22. Petaja JM, Griffin JH. Activated protein C resistance: What have we learned now that the dust has settled? Ann Med 1997;29:469-472
23. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346:1133-1134
24. Ridker P, Hennekens C, Lindpainter K, Stampfer M, Eisenberg P, Miletich J. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332:912-917
25. Rosendaal FR, Siscovick DS, Schwartz SM, Beverly RK, Psaty BM, Longstreth WT Jr et al. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood 1997; 89:2817-2821
26. Samani NJ, Lodwick D, Martin D, Kimber P. Resistance to activated protein C and risk of premature myocardial infarction. Lancet 1994;344:1709-1710
27. Scat Y, Morin Y, Morel C, Haut J. Retinal vein occlusion and resistance to activated protein C. J Fr Ophthalmol 1995; 18:758-762
28. Schroeder W, Koesling M, Wulff K, Wehnert M, Herrmann FH. Large-scale screening for factor V Leiden mutation in a North-Eastern German population. Haemostasis 1996; 26:233-236
29. Simioni P, de Ronde H, Prandoni P, Saladini M, Bertina RM, Girolami A. Ischemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds. Stroke 1995; 26:885-890
30. Talmon T, Scharf J, Mayer E, Lanir N, Miller B, Brenner B. Retinal arterial occlusion in a child with factor V Leiden and thermolabile methylene tetrahydrofolate reductase mutations. Am J Ophthalmol 1997; 124:689-691
31. Vignes S, Wechsler B, Elmaleh C, Cassoux N, Horellou MH, Godeau P. Retinal arterial occlusion associated with resistance to activated protein C (letter). Br J Ophthalmol 1996; 80:1111
32. Williamson TH, Rumley A, Lowe GDO. Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study. Br J Ophthalmol 1996; 80:203-208
33. Witt I. APC-Resistenz (Faktor-V-Mutation). Klinische Bedeutung, Pathophysiologie und Diagnostik. Deutsch Ärztebl 1998; 38:1815-1820
34. Zuber M, Toulon P, Marnet L, Mas JL. Factor V Leiden mutation in cerebral venous thrombosis. Stroke 1996, 27:1721-1723